- Home
- AUDC vs XGN Comparison
AUDC vs XGN Comparison
Compare AUDC & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUDC | XGN |
|---|---|---|
| Founded | 1992 | 2002 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.0M | 253.9M |
| IPO Year | 1999 | 2019 |
Fundamental Metrics
Financial Performance| Metric | AUDC | XGN |
|---|---|---|
| Price | $8.95 | $6.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $11.67 | ★ $13.67 |
| AVG Volume (30 Days) | 111.8K | ★ 246.3K |
| Earning Date | 02-03-2026 | 11-04-2025 |
| Dividend Yield | ★ 4.40% | N/A |
| EPS Growth | ★ 15.76 | N/A |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $244,553,000.00 | $63,599,000.00 |
| Revenue This Year | $2.52 | $22.15 |
| Revenue Next Year | $3.15 | $15.26 |
| P/E Ratio | $19.56 | ★ N/A |
| Revenue Growth | 0.15 | ★ 14.08 |
| 52 Week Low | $8.01 | $2.67 |
| 52 Week High | $12.72 | $12.23 |
Technical Indicators
Market Signals| Indicator | AUDC | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.72 | 30.79 |
| Support Level | $8.79 | $6.37 |
| Resistance Level | $9.20 | $7.29 |
| Average True Range (ATR) | 0.25 | 0.35 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 50.69 | 30.82 |
Price Performance
Historical ComparisonAbout AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.